Biotech Investors & VC Firms in Asia-Pacific
746 firms in this list, with a median first check of $500K. 161 of them lead rounds. Generated from verified public data and updated continuously.
AngelMD
DenverSeed–Series A
2 people
Bas1s Ventures
Series A–Late Stage
Bija Ventures
AspenPre-Seed–Series A
2 people
Crede CapitalGroup
Los Angeles$5M – $50M
Ela Capital
TorontoPre-Seed–Growth
3 people
Tamil Ventures
San FranciscoPre-Seed–Series A$100K – $250K
Aescuvest
Frankfurt am MainSeed–Series B
1 person
Elmirate Capital
DubaiSeed–Late Stage$15M – $150M
SRI Ventures
Menlo ParkPre-Seed–Seed
2 people
R2 Venture Partners
Seed
Trans-it Capital
Palo AltoSeed
1 person
Next Sequence
2 people
CARELA Holding GmbH
Hamburg
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Start2 Group
MunichSeed–Growth
A. M. Pappas & Associates
DurhamPre-Seed–Series A
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
DSLH Holding GmbH
WuppertalGrowth$550K
1 person
HSBC Innovation Ventures
LondonSeed–Late Stage
1 person
Unveil Pharma
BostonPre-Seed–Series A
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
RMGP Biopharma Investment Fund
HerzliyaSeed–Series A
6 people
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
10x Genomics
Pleasanton
4 people
Related lists
Investors & VC Firms in North America (13321)Investors & VC Firms in United States (12313)Investors & VC Firms in Europe (6087)AI & Machine Learning Investors & VC Firms (5355)Investors & VC Firms in Global (5320)Fintech Investors & VC Firms (5141)Healthtech Investors & VC Firms (4658)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4426)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.



























